Bioceltix

Bioceltix EBIT Margin

The EBIT Margin (Operating Margin) of Bioceltix (BCX.WA) as of Oct 21, 2026 is -36,934.63 %. In the previous year, EBIT Margin (Operating Margin) was -251,764.00 % — a change of -85.33% (higher).

EBIT Margin

-36,934.63 %

YoY

-85.33%

Last updated:

EBIT Margin (Operating Margin) of Bioceltix is 2020 -36,934.63 % . EBIT Margin (Operating Margin) of Bioceltix was 2019 -251,764.00 % . It decreases by -85.33% higher compared to the previous year.

For Bioceltix, the operating (EBIT) margin of -36,934.6% is down versus -20,864.9% a few years ago.

The Bioceltix EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-20,864.88 PLN
Jan 1, 2019
-251,764.00 PLN
Jan 1, 2020
-36,934.63 PLN
The Bioceltix EBIT Margin history
YEAREBIT MarginYoY
-36,934.63 %-85.33%
-251,764.00 %+1,106.64%
-20,864.88 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bioceltix Stock analysis

What does Bioceltix do? Bioceltix SA focuses on research and development within the field of veterinary medicine, specifically targeting the treatment of companion animals. The company develops candidates for veterinary medicinal products by utilizing the immunomodulatory properties of mesenchymal stem cells as the active substance. This scientific approach allows the firm to conduct research and development works that facilitate clinical trials and the full registration of these medicinal products with the European Medicines Agency, adhering to standards similar to those for human medicines. Bioceltix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioceltix stock

EBIT Margin (Operating Margin) of Bioceltix is -36,934.63 % in 2020.

EBIT Margin (Operating Margin) of Bioceltix changed from -251,764.00 % to -36,934.63 %, representing a -85.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Bioceltix since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Bioceltix with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Bioceltix

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Bioceltix